Market report
Cardiovascular drug tenders in Portugal — market report, September 2026
Cardiovascular drug tenders in Portugal in September 2026: 127 tenders published (+159% year on year), estimated at €11,044 in total, and 112 contracts awarded (+489% month on month, +32% year on year), worth €17,705,754 (contract value). Buyers with the most tenders: Unidade Local de Saúde da Região de Leiria, E. P. E. (25), Unidade Local de Saúde de Viseu Dão-Lafões, E. P. E. (14) and Unidade Local de Saúde de Almada-Seixal, EPE (11); most contracts won: Hikma Farmacêutica (Portugal) Sa. (11), Janssen Cilag Farmaceutica, Lda. (11) and Novartis Farma-Prod.farmacêuticos,sa. (10). On average 20.2 bids per contract; 0% of contracts had a single bid. Report made on 27 October 2026.
- Tenders published
- 127
- Contracts awarded
- 112
- Contract value contract
- €17,705,754
- Bids per contract
- 20.2
The highlighted bar is September 2026. Hover a bar for its figure; the table below has every value.
| Figure | September 2026 | August 2026 | Change | September 2025 | Change |
|---|---|---|---|---|---|
| Tenders published | 127 | 7 | +1,714% | 49 | +159% |
| Estimated value | €11,044 | — | — | €835,705 | -99% |
| Buyers | 17 | 4 | +325% | 7 | +143% |
| Contracts awarded | 112 | 19 | +489% | 85 | +32% |
| Contract value (contract) | €17,705,754 | €2,544,887 | +596% | €1,608,020 | +1,001% |
| Winners | 31 | 10 | +210% | 22 | +41% |
| Bids per contract | 20.2 | 16.0 | — | — | — |
| Single-bid contracts | 0% | 0% | — | — | — |
Buyers with the most tenders
Companies with the most contracts
Procedures
The report's aggregates: the figures, the comparisons and the top lists by name and count.
All reports: Cardiovascular and anticoagulant drugs
Questions and answers
- How many cardiovascular drug tenders were published in Portugal in September 2026?
- 127 (by 17 buyers); for comparison, August 2026: 7, September 2025: 49.
- Who won the most cardiovascular drug tenders in Portugal in September 2026?
- By number of contracts: Hikma Farmacêutica (Portugal) Sa. (11), Janssen Cilag Farmaceutica, Lda. (11), Novartis Farma-Prod.farmacêuticos,sa. (10), Fresenius Kabi Pharma Portugal (8) and Orionfin Unipessoal Lda. (6); 31 companies won contracts in all.
- Which buyers published the most cardiovascular drug tenders in September 2026?
- Unidade Local de Saúde da Região de Leiria, E. P. E. (25), Unidade Local de Saúde de Viseu Dão-Lafões, E. P. E. (14), Unidade Local de Saúde de Almada-Seixal, EPE (11), Unidade Local de Saúde de Santa Maria, E. P. E. (10) and Unidade Local de Saúde de Entre O Douro e Vouga, E.P.E (10).
- How competitive were cardiovascular drug tenders in Portugal in September 2026?
- On average 20.2 bids per contract (68 contracts with a known number of bids); 0% of contracts had a single bid.
- What were the contracts worth in September 2026?
- €17,705,754 (contract value, 112 contracts); median about €5,500.
How the report is made
Tenders published: the tenders of the sector or topic whose first notice is dated in the month (a tender counts in its sector and in up to three topics). Contracts awarded: the awards dated in the month, whenever their tender was published. Values in EUR, by value kind (never added together); medians are approximate (±3 %). Comparisons: with the reports of the previous month and of the same month a year earlier, each made the same way. The report was made on 27 October 2026 from the data of that day and is not changed afterwards; sources publish late, so later data for the month are not in it.